Your browser doesn't support javascript.
loading
Availability and use of rapid diagnostic tests for the management of acute childhood infections in Europe: A cross-sectional survey of paediatricians.
Dewez, Juan Emmanuel; Pembrey, Lucy; Nijman, Ruud G; Del Torso, Stefano; Grossman, Zachi; Hadjipanayis, Adamos; Van Esso, Diego; Lim, Emma; Emonts, Marieke; Burns, James; Gras-LeGuen, Christèle; Kohlfuerst, Daniela; Dornbusch, Hans Jürgen; Brengel-Pesce, Karen; Mallet, Francois; von Both, Ulrich; Tsolia, Maria; Eleftheriou, Irini; Zavadska, Dace; de Groot, Ronald; van der Flier, Michiel; Moll, Henriëtte; Hagedoorn, Nienke; Borensztajn, Dorine; Oostenbrink, Rianne; Kuijpers, Taco; Pokorn, Marko; Vincek, Katarina; Martinón-Torres, Federico; Rivero, Irene; Agyeman, Philipp; Carrol, Enitan D; Paulus, Stéphane; Cunnington, Aubrey; Herberg, Jethro; Levin, Michael; Mujkic, Aida; Geitmann, Karin; Da Dalt, Liviana; Valiulis, Arunas; Lapatto, Risto; Syridou, Garyfallia; Altorjai, Péter; Torpiano, Paul; Størdal, Ketil; Illy, Károly; Mazur, Artur; Spreitzer, Mateja Vintar; Rios, Joana; Wyder, Corinne.
Afiliación
  • Dewez JE; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Pembrey L; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Nijman RG; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Del Torso S; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Grossman Z; Department of Infectious Diseases, Section of Paediatric Infectious Diseases, Imperial College London, London, United Kingdom.
  • Hadjipanayis A; Research in European Paediatric Emergency Medicine (REPEM).
  • Van Esso D; ChildCare WorldWide, Padova, Italy.
  • Lim E; European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).
  • Emonts M; European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).
  • Burns J; Adelson School of Medicine, Ariel University, Ariel, Israel.
  • Gras-LeGuen C; Pediatric Clinic, Maccabi Healthcare Services, Tel Aviv, Israel.
  • Kohlfuerst D; European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).
  • Dornbusch HJ; Paediatric Department, Larnaca General Hospital, Larnaca, Cyprus.
  • Brengel-Pesce K; Medical School, European University Cyprus, Nicosia, Cyprus.
  • Mallet F; European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).
  • von Both U; Primary Care Paediatrician, Health Care Centre Pere Grau, Barcelona, Spain.
  • Tsolia M; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Eleftheriou I; Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Zavadska D; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • de Groot R; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • van der Flier M; Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Moll H; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Hagedoorn N; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Borensztajn D; Centre d'Investigation Clinique CIC1413, INSERM-Nantes University Hospital, Nantes, France.
  • Oostenbrink R; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Kuijpers T; Medical University of Graz, Graz, Austria.
  • Pokorn M; European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).
  • Vincek K; Medical University of Graz, Graz, Austria.
  • Martinón-Torres F; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Rivero I; BioMérieux, Lyon, France.
  • Agyeman P; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Carrol ED; BioMérieux, Lyon, France.
  • Paulus S; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Cunnington A; University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
  • Herberg J; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Levin M; P. and A. Kyriakou Children's Hospital, Athens, Greece.
  • Mujkic A; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Geitmann K; P. and A. Kyriakou Children's Hospital, Athens, Greece.
  • Da Dalt L; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Valiulis A; Children Clinical University Hospital, Riga, Latvia.
  • Lapatto R; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Syridou G; Radboud University Medical Center, Nijmegen, the Netherlands.
  • Altorjai P; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Torpiano P; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Størdal K; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Illy K; Research in European Paediatric Emergency Medicine (REPEM).
  • Mazur A; Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Spreitzer MV; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
  • Rios J; Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Wyder C; Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
PLoS One ; 17(12): e0275336, 2022.
Article en En | MEDLINE | ID: mdl-36538525
ABSTRACT

BACKGROUND:

Point-of-care-tests (POCTs) have been advocated to optimise care in patients with infections but their actual use varies. This study aimed to estimate the variability in the adoption of current POCTs by paediatricians across Europe, and to explore the determinants of variability. METHODS AND

FINDINGS:

A cross-sectional survey was conducted of hospital and primary care paediatricians, recruited through professional networks. Questions focused on the availability and use of currently available POCTs. Data were analysed descriptively and using Median Odds Ratio (MOR) to measure variation between countries. Multilevel regression modelling using changes in the area under the receiver operating characteristic curve of models were used to assess the contribution of individual or workplace versus country level factors, to the observed variation. The commonest POCT was urine dipsticks (UD) which were available to >80% of primary care and hospital paediatricians in 68% (13/19) and 79% (23/29) countries, respectively. Availability of all POCTs varied between countries. In primary care, the country (MOR) varied from 1.61 (95%CI 1.04-2.58) for lactate to 7.28 (95%CI 3.04-24.35) for UD. In hospitals, the country MOR varied from 1.37 (95%CI1.04-1.80) for lactate to 11.93 (95%CI3.35-72.23) for UD. Most paediatricians in primary care (69%, 795/1154) and hospital (81%, 962/1188) would use a diagnostic test in the case scenario of an infant with undifferentiated fever. Multilevel regression modelling showed that the country of work was more important in predicting both the availability and use of POCTs than individual or workplace characteristics.

CONCLUSION:

There is substantial variability in the adoption of POCTs for the management of acute infections in children across Europe. To inform future implementation of both existing and innovative tests, further research is needed to understand what drives the variation between countries, the needs of frontline clinicians, and the role of diagnostic tests in the management of acute childhood infections.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas en el Punto de Atención / Prueba de Diagnóstico Rápido Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans / Infant Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas en el Punto de Atención / Prueba de Diagnóstico Rápido Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans / Infant Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido